Jeff Sands
 | Jeff Sands is the Juha P. Kokko Professor of Medicine and Physiology, Director of the Renal Division, and Associate Dean for Clinical and Translational Research at Emory University School of Medicine. He is a graduate of Harvard College and Boston University School of Medicine, and trained in medicine at the University of Chicago Division of the Biological Sciences at the Pritzker School of Medicine and the National Institute of Health's (NIH) National Heart, Lung, and Blood Institute (NHLBI). Following research fellowship training in the Laboratory of Kidney and Electrolyte Metabolism, NHLBI, NIH, he proceeded to a clinical nephrology fellowship at Emory.
Jeff Sands served as Editor-in-Chief of the American Journal of Physiology-Renal Physiology from 2001-2007.
Jeff Sands' research is directed at understanding the physiology of the renal inner medulla and the urine concentrating mechanism. Current research projects are focused on defining the molecular physiology of urea transporters since urea transport is a key component in the urine concentrating mechanism. These studies use models of abnormal concentrating and diluting ability, such as diuretic rats (water or furosemide diuresis), adrenalectomized rats, or rats with diabetes mellitus. Jeff Sands uses a combination of isolated perfused tubule studies to measure urea transport, antibodies to measure changes in the amount, location, phosphorylation, or localization of the urea transport proteins, and Northern analysis and real-time PCR to measure changes in mRNA, and surface biotinylation and confocal microscopy to measure changes in the subcellular localization of urea transporters. |
|---|
| David Harris | David Harris is Associate Dean and Head of the Western Clinical School, University of Sydney. He is also consultant nephrologist at Westmead and Blacktown Hospitals. Currently his clinical research involves progression of chronic renal disease and dialysis. His laboratory research interest is focused on interstitial inflammation and regulatory cells in progressive chronic renal disease. |
|---|
| Richard Kitching | Richard Kitching is a Chief Investigator with the Centre for Inflammatory Disease's Glomerulonephritis Group at Monash University, Melbourne, Australia. He is both a clinician and a scientist, specialising in nephrology. Richard Kitching's research established that the T-helper cell subsets Th1/Th2 are applicable to glomerulonephritis. His findings resulted in a paradigm shift in how immune responses that lead to glomerular injury are viewed. |
|---|
| Philip Poronnik | Philip Poronnik is Professor in the Biomedical Sciences School of the University of Queensland, Brisbane, Australia. His research interests are in the molecular physiology of epithelial ion transport : changes in membrane transport that occur in the kidney in diabetes mellitus. His research aims at characterising the molecular mechanisms that regulate albumin uptake by the proximal tubule of the kidney and establishing the relationship between albumin uptake and sodium retention. |
|---|
| Glenda Gobe | Glenda Gobe is Associate Professor in Molecular and Cellular Pathology and Co-Director of the Kidney Disease Research Group in the School of Medicine, University of Queensland. Her research has focussed on the molecular controls of apoptosis and practical application of these, particularly in acute and chronic kidney disease. Her recent research has investigated the effects of growth factors, cytokines and signal transduction pathways that affect cell death and survival of various kidney cells under disease states. |
|---|
| John Bertram | John Bertram is Professor and Head of the Department of Anatomy and Developmental Biology in the School of Biomedical Sciences at Monash University. Research in his laboratory focuses on kidney and ureter development, regulation of nephron number during kidney development, and renal regeneration. The group also researches the consequences of low nephron number in adulthood for kidney and cardiovascular health, in both animal models and humans (white and Aboriginal Australians, white and African Americans, and Senegalese). |
|---|
| David Weiner | David Weiner has a long-standing interest in the cellular mechanisms and the regulation of acid-base homeostasis. At present, Dr. Weiner's laboratory has functionally identified fourteen transporters involved in proton or bicarbonate transport in the renal collecting duct and has examined several characteristics of their regulation. He is currently examining the role and regulation of a novel ammonia transporter family of proteins. These proteins, the Rh glycoprotein family, are a component of an extended family of proteins that includes members in all known organisms. Studies from his laboratory to date have demonstrated the presence of these protein in the renal collecting duct, liver and throughout the intestinal tract. Moreover, Dr. Weiner's studies have shown that carrier-mediated ammonia transport, not non-ionic NH3 diffusion, is the critical component of renal collecting duct ammonia transport. |
|---|
| Alan Davidson | Alan Davidson is a cell biologist at the Center for Regenerative Medicine, Massachusetts General Hospital and Assistant Professor at Harvard Medical School. He works on the formation and regeneration of the kidney using zebrafish as a model organism. His interests include nephron segmentation and development, and he is investigating the remarkable regenerative abilities of the zebrafish kidney that enable it to grow completely new nephrons following injury. |
|---|
| Stefan Broer | Stefan Broer is Professor in the School of Biochemistry & Molecular Biology at the Australian National University in Canberra, Australia. His research is focused on molecular and pathophysiological aspects of Intestinal, renal and brain amino acid transport processes. In particular his laboratory works on the molecular understanding of Hartnup Disorder and Iminoglycinuria, two disorders affecting amino acid transport. |
|---|
| Daniel Markovich | Daniel Markovich is an Associate Professor of Physiology in the School of Biomedical Sciences of the University of Queensland, Brisbane, Australia. His research interests are in the study of the physiology, pathophysiology and regulation of mammalian ion transporters, involved in mediating transcellular movement of ions (sulfate, chloride, phosphate) across epithelial cells of the kidney, small intestine, liver and brain. His lab has cloned and characterized several ion transporters and recently generated transporter null mice, in order to determine their physiological roles in the body. |
|---|
| Zoltan Endre | Zoltan Endre is Professor and Head of the Department of Medicine at the University of Otago - Christchurch, and a Nephrologist at the Christchurch Hospital. His main research interests are the mechanisms and modulation of acute renal failure, mechanisms of progression in chronic renal failure and the use of magnetic resonance for renal studies. Current studies include modeling of renal autoregulation and nephron flow; vascular mechanisms of progression of diabetic kidney and cardiac disease; biomarkers in early detection of acute kidney injury; and volatile organic compounds in breath as markers of renal function and dysfunction. |
|---|
| Mike Eccles | Mike Eccles is head of the Developmental Genetics Group, Pathology Department, Otago University. The research of the group is centered on the role that developmental genes play in cancer, congenital childhood disease, and fetal development. A new research interest in the group is polycystic kidney disease. The goals of the group are: to identify and characterize relevant molecular pathways involved in human cancer (particularly kidney cancer), and in polycystic kidney disease; to develop new targeted molecular therapies that will be useful to treat polycystic kidney disease and cancer; and to investigate molecular pathways involved in the development of organs and tissues. |
|---|
| Tony Poole | Tony Poole is a Professorial Research Fellow in the Department of Medical and Surgical Sciences, University of Otago. His research has focused on connective tissue biology and the influence of mechanical forces on the cellular expression of extracellular matrices. Studies on primary cilia in a range of connective tissues have established a biological continuum between the extracellular matrix, the primary cilium and the Golgi apparatus. This research has recently been extended to include studies on the role of interstitial fibroblast primary cilia in the pathogenesis of fibrosis in polycystic kidney diseases. |
|---|
| Rob Walker | Rob Walker is Head of the Department Medical and Surgical Sciences, University of Otago and Consultant Physician in Nephrology, Dunedin Hospital, Dunedin. His research is wide ranging including cardiovascular risk factors in chronic kidney disease (lipid abnormalities and changes in vascular reactivity, alterations in vasoactive hormones, hypertension); drug nephrotoxicity (mechanisms of lithium induced renal injury including aquaporins); oxidative stress in Chronic Kidney Disease; interventions in acute renal failure and renal genetics, developmental abnormalities (renal cystic disease). |
|---|
| John Leader | John Leader is Honorary Associate Professor in the Department of Medical and Surgical Sciences, University of Otago. His research interests have focused on the control of cell volume in cells and include NMR studies of protein/osmolyte interactions; physiology and pathophysiology of water balance, renal function, and cryobiology. He also has a long standing research interest in marine insects – both physiology and systematics. |
|---|
>> Back to the top
|
Sponsors
|
